U.S. market Closed. Opens in 1 day 21 hours 49 minutes

BRTX | BioRestorative Therapies, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Revenue145.80K119.80K46.00K77.00K130.00K111.00K81.00K36.35K628.91K416.00K1.68K15.59KN/AN/A
Cost of RevenueN/A280.67K205.21KN/AN/AN/A259.26K102.00261.50K213.83K208.001.31KN/AN/A
Gross Profit145.80K-160.87K-159.21K77.00K130.00K111.00K-178.26K36.25K367.41K202.16K1.47K14.28KN/AN/A
Operating Expenses15.37M18.98M26.35M2.83M8.56M7.76M8.46M7.83M7.54M5.12M4.75M5.59M3.55M2.07M
Selling, General & Admin11.33M15.58M25.62M1.95M6.84M6.25M6.30M4.95M5.43M3.69M3.16M5.17M3.54M2.06M
Research & Development4.03M3.51M729.06K876.83K1.72M1.51M2.15M2.88M2.11M1.43M1.59M416.18K12.00K11.62K
Other Operating ExpensesN/A-110.52K-16.18M-658.15K-1.87M-1.42M-59.94K-46.60K1.13M1.10M779.25K3.81M2.06MN/A
Operating Income-15.22M-18.97M-26.31M-2.75M-8.43M-7.65M-8.37M-7.80M-7.17M-4.92M-4.75M-5.57M-3.55M-2.07M
Other Expenses / Income4.80M5.75M-18.00M-8.52M-6.22M-4.87M-1.07M-839.03K-753.12K-665.11K-998.92K-964.27K-521.93K-170.31K
Before Tax Income-10.42M-18.49M-44.30M-11.27M-14.65M-12.52M-9.44M-8.64M-7.92M-5.59M-5.75M-6.54M-4.07M-2.24M
Income Tax ExpensesN/A-479.26K-14.36M981.99K3.27M-1.65M1.03M717.34K263.58K285.27K371.28K591.81K521.93K194.46K
Net Income-10.42M-18.02M-29.94M-12.25M-17.92M-12.52M-9.44M-8.64M-7.92M-5.59M-5.75M-6.54M-4.07M-2.26M
Interest ExpensesN/A11.65K1.82M1.64M5.14M3.22M1.09M763.94K263.58K285.27K371.28K591.81K260.01K24.16K
Basic Shares Outstanding4.22M3.62M1.19M394.70K5.57K2.93K1.53K1.17K827.00424.00238.00186.00151.001.07K
Diluted Shares Outstanding4.22M3.62M1.19M394.70K5.57K2.93K1.53K1.17K827.00424.00238.00186.00151.001.07K
EBITDA-15.06M-18.85M-26.22M-9.48M-9.29M-9.06M-8.10M-7.61M-7.11M-4.83M-4.65M-5.85M-3.38M-1.85M
EBITDA Margin-10,325.82%-15,737.46%-56,997.32%-12,312.44%-7,147.23%-8,158.25%-9,997.56%-20,943.26%-1,129.99%-1,160.06%-276,634.46%-37,555.36%0.00%0.00%
EBIT-10.42M-18.48M-42.49M-9.63M-9.51M-10.94M-7.33M-7.16M-7.40M-5.02M-5.01M-5.35M-3.29M-2.05M
EBIT Margin-7,145.20%-15,428.31%-92,365.06%-12,509.79%-7,314.50%-9,859.82%-9,049.19%-19,680.95%-1,176.04%-1,206.04%-298,132.86%-34,338.93%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙